Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-23-001422
Filing Date
2023-08-02
Accepted
2023-08-02 12:50:01
Documents
39
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q acbm_10q.htm   iXBRL 10-Q 369132
2 CERTIFICATION acbm_ex311.htm EX-31.1 13985
3 CERTIFICATION acbm_ex321.htm EX-32.1 5745
  Complete submission text file 0001640334-23-001422.txt   1735036

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA acro-20230331.xsd EX-101.SCH 21612
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE acro-20230331_lab.xml EX-101.LAB 126969
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acro-20230331_cal.xml EX-101.CAL 26137
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acro-20230331_pre.xml EX-101.PRE 97791
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acro-20230331_def.xml EX-101.DEF 40927
33 EXTRACTED XBRL INSTANCE DOCUMENT acbm_10q_htm.xml XML 129695
Mailing Address 12175 VISIONARY WAY SUITE 1160 FISHERS IN 46038
Business Address 12175 VISIONARY WAY SUITE 1160 FISHERS IN 46038 (317) 286-6788
ACRO BIOMEDICAL CO., LTD. (Filer) CIK: 0001622996 (see all company filings)

EIN.: 471950356 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55643 | Film No.: 231134641
SIC: 7900 Services-Amusement & Recreation Services